1 minute read

Transforming how we

treat breast cancer in East London

Breast cancer is the most common form of cancer affecting women in the UK today, with one woman diagnosed every ten minutes and 32 people dying every day. Outcomes are poorer for women in East London, and patients tend to be younger, present with symptoms later and with the more aggressive breast cancers, compared to the rest of the UK.

With your support, we will build a new Breast Cancer Centre. This state-ofthe-art facility will bring together surgical services under one roof. Over 80% of patients have surgery as part of their treatment and this new centre will centralise surgery and post-surgery care, improving every stage of the patient experience.

Behind this proposed centre is a worldclass team of breast cancer specialists whose ambition is to create a new standard of excellence in breast cancer care.

As well as improving breast cancer outcomes for patients today, it will help make a significant contribution to global research, saving lives for generations. Your support will make this centre a reality. Together we can transform how we treat breast cancer in East London.

Clinical trials underpin the future of healthcare. They are vitally important in the development of new treatments, medications or devices, by ensuring they are safe and effective in people.

Lack of diversity in clinical trials means treatments can be less effective, and less suitable, for communities such as those in East London, which can in turn contribute to lower life expectancy and poorer health outcomes.

To address this, we are building a new Clinical Research Facility in Whitechapel. This world-class facility will enable research teams to develop innovative new therapies, putting East London at the forefront of cutting-edge healthcare innovations.

The new centre will significantly expand local clinical participation in trials and will make sure people in East London benefit from the results of clinical studies.

Clinical trials in this area will not only make better, more tailored treatments for the local population, but for millions of underrepresented people around the world. With your support, we can build this centre and develop the life-saving treatments of tomorrow.

This article is from: